Semaglutide for alcohol use disorder after weight loss surgery
Treatments studied
Part of Mental health clinical trials.
This trial tests if a once-weekly diabetes medication (semaglutide) can help people with alcohol use disorder who have had gastric bypass or sleeve gastrectomy in the past 7 years. It may reduce alcohol cravings or drinking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have had gastric bypass or sleeve gastrectomy within the last 7 years
- Your body mass index (BMI) is 30 or higher (or 27+ with a weight-related medical condition) and below 51
- You currently have alcohol use disorder as defined by standard psychiatric criteria
- You are not currently trying to quit alcohol or receiving other treatment for alcohol use disorder
- You are not pregnant, breastfeeding, and if able to become pregnant, you agree to use effective birth control
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if semaglutide (a GLP-1 RA medicine) can reduce alcohol consumption and improve liver fat and metabolism in people with obesity and fatty liver disease who drink above certain levels.
This study tests whether a medication (semaglutide) can help veterans reduce or stop drinking alcohol. It is for veterans who drink heavily and have alcohol use disorder, and who are interested in cutting down.
This trial tests whether semaglutide (a medicine that helps control blood sugar and weight) can improve outcomes for people with type 1 diabetes who have a higher body weight. It may help if you have had type 1 diabetes for at least 3 years and have a BMI of 30 or more, or 27 or more with a related health problem.
This study compares different diets to see how they affect “arterial stiffness” (how hard the blood vessels are) in people with obesity who are starting semaglutide for weight management. It may help find a diet approach that improves heart and blood-vessel health while you use semaglutide.
This trial tests two medicines — semaglutide and naltrexone — taken together to help reduce alcohol cravings and drinking. It aims to see if this combination is more effective than standard treatment for alcohol use disorder.
This study tests whether semaglutide, a medication that helps with weight loss, can also reduce alcohol cravings and drinking in people with alcohol use disorder. It may help you drink less and lose weight.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.